Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

BLTEBLTE
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in Belite Bio, Inc. ADR

JPMORGAN CHASE & CO holds 33,181 shares of BLTE (Belite Bio, Inc. ADR), worth $5.1M as of 2026-Q2. The position was increased (+11.1Kx shares). BLTE represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$5.1M

Current Shares

33,181

Total Value Change

+$4.2M

Total Shares Change

+18,545

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
33,181
+11.1Kx
$5.1M0.0%$153.99
44
2026-Q1
Unchanged
3
0.0%
$4480.0%$167.88
0
2025-Q4
Decreased
3
-100.0%
$4800.0%$160.82
0
2025-Q3
Increased
19,618
+190.3%
$1.5M0.0%$73.00
28
2025-Q2
Decreased
6,757
-17.2%
$389,8790.0%$59.04
0
2025-Q1
Decreased
8,162
-44.2%
$540,4880.0%$66.70
0
2024-Q4
New
14,636
-
$923,5320.0%$61.97
35

Other major holders of BLTE: UBS Group AG, RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used